Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GTF2IP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC25A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPD52L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL2BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MGAT4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506098 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MTIF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLUL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLOD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MORC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C10orf10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP1B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on